Has Jenna Wishnew, MD received payments from drug or device companies?

Yes. Drug and device makers reported $156,943 in general payments to Jenna Wishnew, MD across 271 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jenna Wishnew, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jenna Wishnew, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jenna Wishnew, MD

Surgery · Frisco, TXNPI 1932309283

Payments from drug & device makers

$156,943in general payments, 2019–2025

Across 271 payments — averaging $579.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Kerecis Limited$153K
Smith+Nephew$1K
Acell, Inc.$237
Musculoskeletal Transplant Foundation Inc.$233
Viiv Healthcare Company$204
Innovation Technologies Inc$175
plus $2K from 38 others

What the payments were for

Speaking & faculty fees$118,12575%
Travel & lodging$20,98713%
Food & beverage$9,7316%
Education$7,8755%
Gifts$2250%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Kerecis Limited	116	$152,666
Smith+Nephew	44	$1,216
Acell, Inc.	2	$237
Musculoskeletal Transplant Foundation Inc.	7	$233
Viiv Healthcare Company	11	$204
Innovation Technologies Inc	3	$175
Davol Inc.	2	$169
Abbott	2	$158
Avita Medical Americas, LLC	6	$151
Teleflex LLC	1	$143
Enterra Medical, Inc.	3	$122
Merck	4	$105
Cumberland Pharmaceuticals, Inc.	4	$90
Medtronic(2 entities)	2	$87
Hartmann USA, Inc.	3	$87
Paratek Pharmaceuticals, Inc.	5	$87
Aroa Biosurgery Incorporated	8	$85
Convatec Inc.	3	$79
Cashflow Solutions, LLC	3	$74
Takeda Pharmaceuticals U.S.A., Inc.	2	$55
KCI USA, Inc.	3	$51
Acera Surgical, Inc.	2	$49
ETS Wound Care LLC	5	$48
Tactile Systems Technology Inc	2	$45
Integra Lifesciences Corporation	3	$45
Polynovo North America LLC	2	$44
Medela LLC	3	$43
CPM Medical Consultants, LLC	1	$36
Bsn Medical Inc	2	$35
Theratechnologies Inc.	2	$35
Aimmune Therapeutics, Inc.	1	$32
Ferring Pharmaceuticals Inc.	1	$31
Hydrofera LLC	2	$31
Organogenesis Inc.	1	$24
Gilead	1	$20
Urgo Medical North America, LLC	1	$20
Intuitive Surgical	1	$19
Biowound Solutions, Inc.	1	$19
Reapplix Inc.	1	$17
AbbVie	1	$17
Bard Peripheral Vascular, Inc.	1	$17
Next Science LLC	1	$16
Stability Biologics, LLC	1	$15
Osiris Therapeutics Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$156,943 in reported general payments places this provider in the 95th percentile of 1,830 surgery providers in Texas.

See all surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$1,404,548

Medicare patients

229

Services billed

2,938

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gentamicin Sulfate	22	$1,050
Promethazine Hcl	62	$887
Pantoprazole Sodium	30	$614
Famotidine	53	$336
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	30	$221
Diphenhydramine Hcl	13	$205
Sodium Chloride0.9 % Sodium Chloride	54	$165
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	11	$153
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	25	$112
Doxycycline Hyclate	11	$107
Furosemide	30	$92
Ciprofloxacin Hcl	11	$80

Paid to pharmacies, not to this prescriber.

Other surgery in Frisco

Funda MericHouston$20.6M
Michael HarkinsTomball$2.7M
Lloyd StegemannCorpus Christi$1.9M
Douglas StoddardAustin$1.4M
Erik WilsonBellaire$1.2M
Thomas SerenaShenandoah$1.2M
Steven FassAustin$989K
Vineet ChoudhryAustin$924K
Isidoro WienerHouston$850K
Andy HawthorneRound Rock$843K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →